Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)

NCT02091882 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Device Latency

Interventions

DRUG: Placebo
COMBINATION_PRODUCT: Combination product of Aripiprazole + IEM + Sensor + MIND1 Application

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.